The DOI matches its Crossref record; 151 of the 153 references it cites were found in a registry or an index.
The Essential Medicinal Chemistry of Curcumin
Open accessAbstract
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One mechanism by which polyphenols could exert protective properties is by generation of a hormetic response to their use85–88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In vivo use of polyphenols (especially curcumin) in some mouse models of AD has been successful77,87, but this has not (yet) been translated to usefulness in human AD2,70,87,88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Takasu, N., Matsuda, T., Ohta, T., Tanaka, Y., & Mori, N. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.004 · Cited by 55
RetractedKundu, P., Mohanty, C., & Sahoo, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.048 · Cited by 51
RetractedDilnawaz, F., Singh, A., & Sahoo, S. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.10.022 · Cited by 33
RetractedSeely, K. A., Levi, M. S., & Prather, P. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151654 · Cited by 21
RetractedNi, Z., Xing, F., Wang, P., & Cao, G. (2007) · Applied Clay Science · doi:10.1016/j.clay.2007.07.008 · Cited by 20
RetractedPrather, P. L., Seely, K. A., & Levi, M. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)45583-3 · Cited by 3
RetractedGlutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“136 However, the extremely long incubation times reported here would require follow-up to exclude the likely possibility of aggregation or degradation in the assay conditions.”
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 1×
“7,133 Subsequent publications have shown that 1 is highly absorptive in the same spectral range as ThT. 134 Most recently, transmission electron microscopy has shown that compound 1 does not a ff ect the aggregation of A β in vitro.”
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y.-J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., & Lin, J.-K. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,705 · cited 6×
“While there are exceptions and some discrepancies about what makes a “ good ” lead, a 27 (B) Autoxidation in bu ff ered medium creates a bicyclopentadione ( 8 ) that is the major degradation product in aqueous conditions.”
InfluentialThe Chemistry of Curcumin: From Extraction to Therapeutic Agent
Priyadarsini, K. (2014) · Molecules · doi:10.3390/molecules191220091 · Cited by 1,510 · cited 1×
“33 Although the multicomponent nature of “ curcumin ” is well documented, that fact and/or the unambiguous assignment of speci fi c structures in a particular preparation is not always clear.”
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Synergy research: approaching a new generation of phytopharmaceuticals.
Wagner, H., & Ulrich-Merzenich, G. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.018 · Cited by 1,296
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Self-citationBalasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Potential anticancer activity of turmeric (Curcuma longa)
Kuttan, R., Bhanumathy, P., Nirmala, K., & George, M. C. (1985) · Cancer Letters · doi:10.1016/0304-3835(85)90159-4 · Cited by 687 · cited 2×
“31 Surprisingly, data on the cytotoxicity of 1 against normal (noncancerous) cell lines are sparse.”
Priyadarsini, K. I. (2009) · Journal of Photochemistry and Photobiology C: Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2009.05.001 · Cited by 680
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 669
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS
Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., & Tsai, T.-H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.03.010 · Cited by 635
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Hudson, S. A., Ecroyd, H., Kee, T. W., & Carver, J. A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07307.x · Cited by 610 · cited 1×
“7,133 Subsequent publications have shown that 1 is highly absorptive in the same spectral range as ThT. 134 Most recently, transmission electron microscopy has shown that compound 1 does not a ff ect the aggregation of A β in vitro.”
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
Vareed, S. K., Kakarala, M., Ruffin, M. T., Crowell, J. A., Normolle, D. P., Djuric, Z., & Brenner, D. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2693 · Cited by 582
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., Canny, S., Du, K., Lukacs, G. L., & Caplan, M. J. (2004) · Science · doi:10.1126/science.1093941 · Cited by 562
Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt146 · Cited by 541
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Thioredoxin Reductase Is Irreversibly Modified by Curcumin
Fang, J., Lu, J., & Holmgren, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414645200 · Cited by 521
Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Link, A., Balaguer, F., & Goel, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.036 · Cited by 497
Garcea, G., Berry, D. P., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., & Gescher, A. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.120.14.1 · Cited by 494
Ghosh, S., Banerjee, S., & Sil, P. C. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.05.022 · Cited by 491
Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.)
Li, S. (2011) · Pharmaceutical Crops · doi:10.2174/2210290601102010028 · Cited by 452
Absorption and tissue distribution of curcumin in rats
Ravindranath, V., & Chandrasekhara, N. (1980) · Toxicology · doi:10.1016/0300-483x(80)90122-5 · Cited by 444
Degradation of Curcumin: From Mechanism to Biological Implications
Schneider, C., Gordon, O. N., Edwards, R. L., & Luis, P. B. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00244 · Cited by 442 · cited 4×
“45,49 This suggests that any report of its activity in an assay that does not either exclude or account for these potential modes of assay interference should be treated with caution.”
InfluentialA detergent-based assay for the detection of promiscuous inhibitors
Feng, B. Y., & Shoichet, B. K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.77 · Cited by 429 · cited 1×
“137 CFTR (Cystic Fibrosis Transmembrane Conductance Regulator).”
An Aggregation Advisor for Ligand Discovery
Irwin, J. J., Duan, D., Torosyan, H., Doak, A. K., Ziebart, K. T., Sterling, T., Tumanian, G., & Shoichet, B. K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01105 · Cited by 418
Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., & Sahebkar, A. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.12.019 · Cited by 406
CLINICAL STUDIES WITH CURCUMIN
Hsu, C.-H., & Cheng, A.-L. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_21 · Cited by 398
Curcumin for chemoprevention of colon cancer
Johnson, J. J., & Mukhtar, H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.005 · Cited by 396
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
NMR Study of the Solution Structure of Curcumin
Payton, F., Sandusky, P., & Alworth, W. L. (2007) · Journal of Natural Products · doi:10.1021/np060263s · Cited by 381
Synergy research: Approaching a new generation of phytopharmaceuticals
Wagner, H. (2011) · Fitoterapia · doi:10.1016/j.fitote.2010.11.016 · Cited by 372
Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses
Mattson, M. P., & Cheng, A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.001 · Cited by 355
Curry Consumption and Cognitive Function in the Elderly
Ng, T.-P., Chiam, P.-C., Lee, T., Chua, H.-C., Lim, L., & Kua, E.-H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj267 · Cited by 353
Dahlin, J. L., Nissink, J. W. M., Strasser, J. M., Francis, S., Higgins, L., Zhou, H., Zhang, Z., & Walters, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019093 · Cited by 351
Self-citationBurgos‐Morón, E., Calderón‐Montaño, J. M., Salvador, J., Robles, A., & López‐Lázaro, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.24967 · Cited by 336
Curcumin, a golden spice with a low bioavailability
Siviero, A., Gallo, E., Maggini, V., Gori, L., Mugelli, A., Firenzuoli, F., & Vannacci, A. (2015) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2015.03.001 · Cited by 333
Liang, G., Shao, L., Wang, Y., Zhao, C., Chu, Y., Xiao, J., Zhao, Y., Li, X., & Yang, S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.044 · Cited by 331
Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats.
Suresh, D., & Srinivasan, K. (2010) · PubMed · Cited by 329
Flanagan, M. E., Abramite, J. A., Anderson, D. P., Aulabaugh, A., Dahal, U. P., Gilbert, A. M., Li, C., Montgomery, J., Oppenheimer, S. R., Ryder, T., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501412a · Cited by 320
Curcumin is an Inhibitor of p300 Histone Acetylatransferase
Neckers, L., Trepel, J., Lee, S., Chung, E.-J., Lee, M.-J., Jung, Y.-J., & Marcu, M. (2006) · Medicinal Chemistry · doi:10.2174/157340606776056133 · Cited by 311
Probing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
Clark, C. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.7.857 · Cited by 298
Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function
Ingólfsson, H. I., Thakur, P., Herold, K. F., Hobart, E. A., Ramsey, N. B., Periole, X., de Jong, D. H., Zwama, M., Yilmaz, D., Hall, K., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500086e · Cited by 294
Asai, A., & Miyazawa, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00868-7 · Cited by 291
Incidence of Alzheimer’s disease in a rural community in India: The Indo–US Study
Chandra, V., Pandav, R., Dodge, H. H., Johnston, J. M., Belle, S. H., DeKosky, S. T., & Ganguli, M. (2001) · Neurology · doi:10.1212/wnl.57.6.985 · Cited by 284
Metabolism of curcumn-studies with [3H]curcumin
Ravindranath, V., & Chandrasekhara, N. (1981) · Toxicology · doi:10.1016/0300-483x(81)90027-5 · Cited by 260
Wahlang, B., Pawar, Y. B., & Bansal, A. K. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.006 · Cited by 259
Cui, L., Miao, J., & Cui, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01238-06 · Cited by 248
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
Bisson, J., McAlpine, J. B., Friesen, J. B., Chen, S.-N., Graham, J., & Pauli, G. F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01009 · Cited by 247
Self-citationAdvances in Nanotechnology-Based Delivery Systems for Curcumin
Sun, M., Su, X., Ding, B., He, X., Liu, X., Yu, A., Lou, H., & Zhai, G. (2012) · Nanomedicine · doi:10.2217/nnm.12.80 · Cited by 239
Stoichiometry and Physical Chemistry of Promiscuous Aggregate-Based Inhibitors
Coan, K. E. D., & Shoichet, B. K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802977h · Cited by 225 · cited 1×
“79,80 Consequently, apparent in vitro selectivity can be in fl uenced by the relative protein concentrations in selectivity counterscreens (i.e., all proteins present: enzyme, carrier, and substrate proteins) and does not always re fl ect selectivity via traditional compound − ligand interactions.”
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
McFadden, R.-M. T., Larmonier, C. B., Shehab, K. W., Midura-Kiela, M., Ramalingam, R., Harrison, C. A., Besselsen, D. G., Chase, J. H., Caporaso, J. G., Jobin, C., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000522 · Cited by 225 · cited 2×
“The transformation of 1 to potentially active metabolites in the gut and the related in fl uence on the gut microbiota (vide supra) 103 seems to be reasonable areas of study as no absorption of the parent compound is necessary.”
Rainey-Smith, S. R., Brown, B. M., Sohrabi, H. R., Shah, T., Goozee, K. G., Gupta, V. B., & Martins, R. N. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516001203 · Cited by 224
Studies on curcumin and curcuminoids VIII. Photochemical stability of curcumin
T�nnesen, H. H., Karlsen, J., & Henegouwen, G. B. (1986) · Zeitschrift f�r Lebensmittel-Untersuchung und -Forschung · doi:10.1007/bf01041928 · Cited by 220
Interactions between traditional Chinese medicines and Western therapeutics.
Chan, E. T., Tan, M., Xin, J., Sudarsanam, S., & Johnson, D. E. (2010) · PubMed · Cited by 218
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
Rajendran, P., Ho, E., Williams, D. E., & Dashwood, R. H. (2011) · Clinical Epigenetics · doi:10.1186/1868-7083-3-4 · Cited by 217
Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding
Coan, K. E. D., Maltby, D. A., Burlingame, A. L., & Shoichet, B. K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801605r · Cited by 204 · cited 1×
“79,80 Consequently, apparent in vitro selectivity can be in fl uenced by the relative protein concentrations in selectivity counterscreens (i.e., all proteins present: enzyme, carrier, and substrate proteins) and does not always re fl ect selectivity via traditional compound − ligand interactions.”
Drug discovery considerations in the development of covalent inhibitors
Mah, R., Thomas, J. R., & Shafer, C. M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.003 · Cited by 193
Ibrutinib: A First in Class Covalent Inhibitor of Bruton's Tyrosine Kinase
Davids, M. S., & Brown, J. R. (2014) · Future Oncology · doi:10.2217/fon.14.51 · Cited by 189
Molecular Orbital Basis for Yellow Curry Spice Curcumin's Prevention of Alzheimer's Disease
Balasubramanian, K. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0603533 · Cited by 188
Mitigating risk in academic preclinical drug discovery
Dahlin, J. L., Inglese, J., & Walters, M. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4578 · Cited by 187 · cited 1×
“132 Additionally, 1 has been reported as an inhibitor of amyloid-β (A β ) fi bril formation and mediator of A β cytotoxicity, also using the ThT assay as a primary readout (IC 50 = 1 − 64 μ M).”
Self-citationKang, S.-K., Cha, S.-H., & Jeon, H.-G. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.165 · Cited by 186
Metabolism and Anticancer Activity of the Curcumin Analogue, Dimethoxycurcumin
Tamvakopoulos, C., Dimas, K., Sofianos, Z. D., Hatziantoniou, S., Han, Z., Liu, Z.-L., Wyche, J. H., & Pantazis, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1839 · Cited by 185
Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway
Thapa, A., Jett, S. D., & Chi, E. Y. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00214 · Cited by 182 · cited 1×
“135 This report attempts to explain the observed cellular protective e ff ects by showing that the oligomers formed by A β in the presence of 1 are nontoxic; i.e., the polyclonal antibody A11, which is reported to speci fi cally detect toxic A β oligomers, does not detect these oligomers.”
Clinical development of curcumin in neurodegenerative disease
Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179
Bora-Tatar, G., Dayangaç-Erden, D., Demir, A. S., Dalkara, S., Yelekçi, K., & Erdem-Yurter, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.042 · Cited by 178
Kutluay, S. B., Doroghazi, J., Roemer, M. E., & Triezenberg, S. J. (2008) · Virology · doi:10.1016/j.virol.2007.11.028 · Cited by 177
Chiu, J., Khan, Z. A., Farhangkhoee, H., & Chakrabarti, S. (2009) · Nutrition · doi:10.1016/j.nut.2008.12.007 · Cited by 171
Unraveling Curcumin Degradation
Gordon, O. N., Luis, P. B., Sintim, H. O., & Schneider, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618785 · Cited by 169
Jagannathan, R., Abraham, P. M., & Poddar, P. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp3050516 · Cited by 169
Drug discovery for a new generation of covalent drugs
Kalgutkar, A. S., & Dalvie, D. K. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688744 · Cited by 166
Yue, G. G. L., Chan, B. C. L., Hon, P.-M., Lee, M. Y. H., Fung, K.-P., Leung, P.-C., & Lau, C. B. S. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.04.039 · Cited by 164
Jöst, C., Nitsche, C., Scholz, T., Roux, L., & Klein, C. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006918 · Cited by 162
The Essential Roles of Chemistry in High-Throughput Screening Triage
Dahlin, J. L., & Walters, M. A. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.60 · Cited by 161
Self-citationAvonto, C., Taglialatela‐Scafati, O., Pollastro, F., Minassi, A., Di Marzo, V., De Petrocellis, L., & Appendino, G. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005959 · Cited by 158
Grießer, M., Pistis, V., Suzuki, T., Tejera, N., Pratt, D. A., & Schneider, C. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178806 · Cited by 156
Esatbeyoglu, T., Ulbrich, K., Rehberg, C., Rohn, S., & Rimbach, G. H. (2015) · Food & Function · doi:10.1039/c4fo00790e · Cited by 152
Synthesis and biological evaluation of aromatic enones related to curcumin
Robinson, T. P., Hubbard, R., Ehlers, T., Arbiser, J. L., Goldsmith, D. J., & Bowen, J. P. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.054 · Cited by 149
Neuroprotective Properties of Curcumin in Alzheimer’s Disease – Merits and Limitations
Chin, D., Huebbe, P., Pallauf, K., & Rimbach, G. H. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990210 · Cited by 147
Curcumin nanodisks: formulation and characterization
Ghosh, M., Singh, A. T. K., Xu, W., Sulchek, T., Gordon, L. I., & Ryan, R. O. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.08.002 · Cited by 143
Khurana, A. L., & Ho, C. (1988) · Journal of Liquid Chromatography · doi:10.1080/01483918808067200 · Cited by 135
Zhang, X., Yin, W., Shi, X.-D., & Li, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.02.009 · Cited by 128
Martino, R. M. C. D., Simone, A. D., Andrisano, V., Bisignano, P., Bisi, A., Gobbi, S., Rampa, A., Fato, R., Bergamini, C., Pérez, D. I., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00894 · Cited by 124
Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2
Lim, T., Lee, S., Huang, Z., Lim, D. Y., Chen, H., Jung, S. K., Bode, A. M., Lee, K. W., & Dong, Z. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0387 · Cited by 122
Zhang, X., Hongmei, Z., Lu, S. Q., & Li, Y. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70629-6 · Cited by 116
Song, Y., Sonawane, N. D., Salinas, D. B., Qian, L., Pedemonte, N., Galietta, L. J. V., & Verkman, A. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407308200 · Cited by 115
Lu, X., Deng, Y., Yu, D., Cao, H., Wang, L., Liu, L., Yu, C., Zhang, Y., Guo, X., & Yu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103067 · Cited by 106
Vanillin and ferulic acid: not the major degradation products of curcumin
Gordon, O. N., & Schneider, C. G. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.011 · Cited by 106
Bustanji, Y. K., Taha, M. O., Almasri, I. M., Al-Ghussein, M. A. S., Mohammad, M. K., & AlKhatib, H. S. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360802364377 · Cited by 104
Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies
Brondino, N., Re, S., Boldrini, A., Cuccomarino, A. F., Lanati, N., Barale, F., & Politi, P. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/174282 · Cited by 103
Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update
Medhi, B., Patyar, S., Rao, R. S., Prasad Byrav, D. S., & Prakash, A. (2009) · Pharmacology · doi:10.1159/000252658 · Cited by 101 · cited 1×
“26 provides evidence that it is su ffi ciently stable, from a pharmacokinetic perspective, to be an e ff ective therapeutic.”
Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer
Mishra, A., Kumar, R., Tyagi, A., Kohaar, I., Hedau, S. T., Bharti, A. C., Sarker, S., Dey, D., Saluja, D., & Das, B. C. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.525 · Cited by 99
Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells
Collins, H. M., Abdelghany, M. K., Messmer, M., Yue, B., Deeves, S. E., Kindle, K. B., Mantelingu, K., Aslam, A., Winkler, G. S., Kundu, T. K., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-37 · Cited by 99
Classification of Drug Permeability with a Caco-2 Cell Monolayer Assay
Volpe, D. A., Faustino, P. J., Ciavarella, A. B., Asafu-Adjaye, E. B., Ellison, C. D., Yu, L. X., & Hussain, A. S. (2007) · Clinical Research and Regulatory Affairs · doi:10.1080/10601330701273669 · Cited by 94
Curcumin as anti-endometriotic agent: Implication of MMP-3 and intrinsic apoptotic pathway
Jana, S., Paul, S., & Swarnakar, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.030 · Cited by 87
Clinical utility of curcumin extract.
Asher, G. N., & Spelman, K. (2013) · PubMed · Cited by 84
Curcumin may impair iron status when fed to mice for six months
Chin, D., Huebbe, P., Frank, J., Rimbach, G. H., & Pallauf, K. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.018 · Cited by 84
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
Simon, R. P., Robaa, D., Alhalabi, Z., Sippl, W., & Jung, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01502 · Cited by 83
Chen, W., Bacanamwo, M., & Harrison, D. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801803200 · Cited by 81
TURMERIC (CURCUMIN) IN BILIARY DISEASES
Oppenheimer, A. (1937) · The Lancet · doi:10.1016/s0140-6736(00)98193-5 · Cited by 75
Hurlstone, D. P., Karajeh, M. A., Sanders, D. S., Drew, S. K., & Cross, S. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40891.x · Cited by 75
Curcumin: A Natural Lead for Potential New Drug Candidates
Oliveira, A., Sousa, E., Vasconcelos, M. H., & Pinto, M. M. M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666151029104611 · Cited by 75
Winter, S., Tortik, N., Kubin, A., Krammer, B. E., & Plaetzer, K. (2013) · Photochemical & Photobiological Sciences · doi:10.1039/c3pp50095k · Cited by 73 · cited 1×
“48,81 Other physicochemical properties of 1 are important considerations when developing assays or evaluating druglike properties.”
Colloidal Aggregation and the in Vitro Activity of Traditional Chinese Medicines
Duan, D., Doak, A. K., Nedyalkova, L., & Shoichet, B. K. (2015) · ACS Chemical Biology · doi:10.1021/cb5009487 · Cited by 72
Analysis and Purification of Bioactive Natural Products: The AnaPurNa Study
Pauli, G. F., Chen, S., Friesen, J. B., McAlpine, J. B., & Jaki, B. U. (2012) · Journal of Natural Products · doi:10.1021/np300066q · Cited by 68 · cited 2×
“51,162 Considering the overwhelming evidence showing the weakness of isolated curcumin (almost always a mixture of curcuminoids) as a viable therapeutic, consideration of holistic approaches that take into account the chemical and PD/PK complexity of turmeric and its broad TxM/nutritional…”
Self-citationDocking-Based Virtual Screening of Covalently Binding Ligands: An Orthogonal Lead Discovery Approach
Schröder, J., Klinger, A., Oellien, F., Marhöfer, R. J., Duszenko, M., & Selzer, P. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3013932 · Cited by 66
Jung, Y., Xu, W., Kim, H., Ha, N., & Neckers, L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.004 · Cited by 59
Dynamic Residual Complexity of the Isoliquiritigenin–Liquiritigenin Interconversion During Bioassay
Simmler, C., Hajirahimkhan, A., Lankin, D. C., Bolton, J. L., Jones, T., Soejarto, D. D., Chen, S., & Pauli, G. F. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf304445p · Cited by 58
Self-citationA cell-based system for screening hair growth-promoting agents
Huh, S., Lee, J., Jung, E., Kim, S.-C., Kang, J.-I., Lee, J., Kim, Y.-W., Sung, Y. K., Kang, H., & Park, D. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0931-0 · Cited by 52
Sharma, C., Sadek, B. S., Goyal, S. N., Sinha, S. K., Kamal, M. A., & Ojha, S. K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/238482 · Cited by 50
Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes
Bamba, Y., Yun, Y. S., Kunugi, A., & Inoue, H. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0507-0 · Cited by 49
Wang, S., Lin, P.-Y., Chiu, Y.-C., Huang, J.-S., Kuo, Y.-T., Jen-Chine, W., & Chen, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134110 · Cited by 48
Jurrmann, N., Brigelius‐Flohé, R., & Böl, G. (2005) · Journal of Nutrition · doi:10.1093/jn/135.8.1859 · Cited by 47
Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels
Xia, M., Shahane, S. A., Huang, R., Titus, S. A., Shum, E., Zhao, Y., Southall, N. T., Zheng, W., Witt, K. L., Tice, R. R., et al. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.016 · Cited by 44
Focus on PAINS: false friends in the quest for selective anti-protozoal lead structures from Nature?
Glaser, J., & Holzgrabe, U. (2016) · MedChemComm · doi:10.1039/c5md00481k · Cited by 41
Glutathione conjugation attenuates biological activities of 6-dehydroshogaol from ginger
Zhang, G., Nitteranon, V., Chan, L. Y., & Parkin, K. L. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.02.073 · Cited by 38
Ciccone, L., Tepshi, L., Nencetti, S., & Stura, E. A. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.09.002 · Cited by 35
Biochemical Composition ofCurcuma longaL. Accessions
Niranjan, A., Singh, S., Dhiman, M., & Tewari, S. K. (2012) · Analytical Letters · doi:10.1080/00032719.2012.751541 · Cited by 33
Gertsch, J. (2016) · Planta Medica · doi:10.1055/s-0042-108340 · Cited by 33
Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
Dey, I., Shah, K., & Bradbury, N. A. (2016) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000284 · Cited by 32
Curcumin induces apoptotic cell death via Oct4 inhibition and GSK‐3β activation in NCCIT cells
Yun, J. H., Park, Y. G., Lee, K., Kim, J., & Nho, C. W. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400739 · Cited by 30
Curcumin inhibits hERG potassium channels in vitro
Hu, C.-W., Sheng, Y., Zhang, Q., Liu, H., Xie, X., Ma, W.-C., Huo, R., & Dong, D. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.11.005 · Cited by 30
Interaction of curcumin with glutathione
Mathews, S., & Rao, M. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90278-v · Cited by 29
Kumar, A., Chetia, H., Sharma, S., Kabiraj, D., Talukdar, N. C., & Bora, U. (2015) · Database · doi:10.1093/database/bav070 · Cited by 28
Curcumin as a potential non-steroidal contraceptive with spermicidal and microbicidal properties
Naz, R. K., & Lough, M. L. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.01.024 · Cited by 26
Hong, D. H., Son, Y. K., Choi, I., & Park, W. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.132 · Cited by 20
A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs
Moghaddam, M. F., Tang, Y., O’Brien, Z., Richardson, S., Bacolod, M. D., Chaturedi, P., Apuy, J. L., & Kulkarni, A. A. (2014) · Drug Metabolism Letters · doi:10.2174/1872312808666140317151735 · Cited by 18 · cited 1×
“Of 55 − 62 However, this mode of action is either purposefully designed into the drug as part of the discovery process or installed after optimization of potency and ADMET properties.”
Schramm, A., Jähne, E. A., Baburin, I., Hering, S., & Hamburger, M. O. (2014) · Planta Medica · doi:10.1055/s-0034-1382907 · Cited by 15
Yuan, D., Yang, X. W., & Guo, J. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600094 · Cited by 14
A Note on Design and Analysis of Clinical Trials
Chiu, S. T. (2012) · Drug Designing Open Access · doi:10.4172/2169-0138.1000102 · Cited by 5
Tomita, M., Matsuda, T., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Ohshiro, K., & Mori, N. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01830.x · Cited by 2
Tomita, M., Matsuda, T., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Ohshiro, K., & Mori, N. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01831.x · Cited by 1
(2001) · PubMed
Research works printed but not linked: 4
- Hanson, M. Is the 2015 Nobel Prize a turning point for traditional Chinese medicine? https://theconversation.com/is-the-2015-nobel-prize-a-turning-point-for-traditional-chinese-medicine-48643 (accessed June 6, 2016). · DOI
- Elias, 2015, Curcumin: Transforming the spice to a wonder drug, Int. J. Pharm. Sci. Res., 6, 2671, 10.13040/ijpsr.0975-8232.6(7).2671-80 · doi:10.13040/ijpsr.0975-8232.6(7).2671-80
- Majeed, 2015, The state of the curcumin market
- Niranjan, 2008, Chemical constituents and biological activities of turmeric (Curcuma longa l.) - a review, J. Food Sci. Technol. (New Delhi, India), 45, 109
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Sharifi-Rad, J., Rayess, Y. E., Rizk, A. A., Sadaka, C., Zgheib, R., Zam, W., Sestito, S., Rapposelli, S., Neffe-Skocińska, K., Zielińska, D., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01021 · Cited by 937
“On the other hand, curcumin seems to offer a promising potential for the therapeutic development from turmeric, categorized as a Generally Recognized As Safe (GRAS) material, with a stable metabolism and low toxicity (Nelson et al., 2017).”
BackgroundInfluentialCurcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
Kotha, R. R., & Luthria, D. L. (2019) · Molecules · doi:10.3390/molecules24162930 · Cited by 890
“Pure CUR has been used in many in vitro studies, whereas most in vivo studies and clinical trials use CCMs mixture [24].”
BackgroundMethodInfluentialAnand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
“It is sold in the market in many forms such as herbal supplements, food additives to increase flavour and aroma, cosmetics ingredients, and as a colouring agent in many food items [72].”
Background
Metadata
- Authors
- Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A.
- Affiliations
- University of Minnesota (US)
- Brigham and Women's Hospital (US)
- University of Illinois Chicago (US)
- Corresponding author
- Walters, Michael A.
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-01-11
- Volume
- 60
- Issue
- 5
- Pages
- 1620-1637
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5346970
- OpenAlex
- W2579340176
- Cited by
- 1,956
- References
- 153
- Citations by year
- 2026: 177 · 2025: 213 · 2024: 204 · 2023: 233 · 2022: 244 · 2021: 257 · 2020: 211 · 2019: 183 · 2018: 157 · 2017: 75
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- University of Illinois Chicago
- Funders
- Office of Dietary Supplements (U41AT008706)
- National Center for Complementary and Integrative Health (U41AT008706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Saffron Plant Research Studies
- Keywords
- curcumin, curcuminoids, turmeric, medicinal chemistry, PAINS, IMPS, bioavailability, clinical trials
- MeSH terms
- Animals, Chemistry, Pharmaceutical, Curcumin, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.